AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nimkis 100mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Blubell Pharma

Salt Composition

Nimesulide (100mg)

Overview Nimkis 100mg Tablet DT

Relief-100 tablets offer pain relief and manage inflammatory conditions like rheumatoid arthritis, post-surgical pain, fever, and menstrual cramps. Take Relief-100 with food to minimize stomach upset. Use the lowest effective dose for the shortest duration. Consistent use is crucial; missed doses reduce efficacy. Common side effects include diarrhea, nausea, and vomiting. Persistent or worsening side effects require medical attention. Inform your doctor of any pre-existing conditions or medications before use. Pregnant or breastfeeding individuals should seek medical advice prior to use. Important: Relief-100 is contraindicated for children under 12 years of age (Ministry of Health and Family Welfare advisory).

Uses of Nimkis 100mg Tablet DT

Fever and pain management

Major Benefits of Nimkis 100mg Tablet DT:

Consume this medication precisely as your physician directs, both in terms of dosage and treatment length. Dissolve the tablet in water before ingestion. Ingest the Nimkis 100mg Tablet DT with a meal.

Common Side effects of Nimkis 100mg Tablet DT:

  • Nausea
  • Diarrhea
  • Vomiting
  • Increased liver enzymes

How to use Nimkis 100mg Tablet DT:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Nimkis 100mg Tablet DT in water before consumption. Administer with food.

How Nimkis 100mg Tablet DT works:

Nimkis 100mg Delayed-Release Tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and edema.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Nimkis 100mg DT tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Nimkis 100mg DT tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Nimkis 100mg extended-release tablets while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Nimkis 100mg Tablet DT on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when administering Nimkis 100mg Tablet DT to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before use. Nimkis 100mg Tablet DT is contraindicated in patients exhibiting severe kidney disease.

LiverLiverUNSAFE

The use of Nimkis 100mg Tablet DT is likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Nimkis 100mg Tablet DT :

Should you forget a dose of Nimkis 100mg Tablet DT, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Nimkis 100mg Tablet DT

LabelValue
Type of Compound Diphenyl ether compound
Potential for Dependence None.
Type of Treatment Medication for Pain Relief

FAQs on Nimkis 100mg Tablet DT

Nimkis 100mg DT tablets are not antibiotics; they're classified as non-steroidal anti-inflammatory drugs (NSAIDs), providing pain relief for diverse ailments.
Nimkis 100mg DT tablets and paracetamol are both classified as non-steroidal anti-inflammatory drugs (NSAIDs), which are analgesics. Concurrent use of these medications is discouraged due to a heightened risk of gastrointestinal ulcers and bleeding. Nevertheless, a physician's consultation is recommended prior to combined administration.
Nimkis 100mg Delayed-Release Tablets are a non-aspirin, non-steroidal anti-inflammatory medication used to alleviate pain.
Using Nimkis 100mg DT tablets as directed by a physician is considered safe.
Use of Nimkis 100mg Delayed-Release tablets for headache relief should only occur under explicit physician guidance.
Taking the recommended dose of Nimkis 100mg Tablet DT will not cause drowsiness. Nevertheless, exceeding the prescribed dosage of Nimkis 100mg Tablet DT may induce drowsiness.
Nimkis 100mg Tablet DT is not formulated with sulfur.
Nimkis 100mg Delayed-Release Tablets are indicated for the management of acute pain, the discomfort associated with osteoarthritis, and primary dysmenorrhea in patients aged 12 years and older.
Nimkis 100mg Delayed-Release tablets may be used concurrently with ibuprofen. While no documented interactions exist, combining these medications is discouraged due to a heightened risk of stomach ulcers and bleeding. Always seek medical advice before simultaneous administration.
Concurrent use of Nimkis 100mg DT tablets and aspirin is permissible. While clinical trials have not revealed any drug interactions, the possibility remains. Physician consultation is advised prior to combined administration.
Taking Nimkis 100mg DT tablets is safe, provided the prescribed dosage and timeframe are followed as directed by your physician.
Nimkis 100mg Tablet DT remains available for purchase in India.
The presence of Nimkis 100mg Tablet DT in breast milk is undetermined. Therefore, medications incorporating Nimkis 100mg Tablet DT should be avoided while breastfeeding.
Using Nimkis 100mg Tablet DT during pregnancy, particularly in the final trimester, is contraindicated. Reports indicate a link between maternal Nimkis 100mg Tablet DT use in late pregnancy and neonatal kidney failure. Pregnant individuals should seek medical advice before using any medication.
Nimkis 100mg Delayed-Release tablets are considered safe for asthmatic patients when administered according to a physician's instructions. Nevertheless, patients with asthma should always disclose their condition and any concurrent medications to their doctor before starting this treatment.
Nimkis 100mg DT tablets are not antibiotics; they're classified as non-steroidal anti-inflammatory drugs (NSAIDs), providing analgesia for diverse ailments.
Nimkis 100mg Delayed-Release Tablets and paracetamol are both non-steroidal anti-inflammatory drugs (NSAIDs), a category of analgesics. Concurrent use of these medications is discouraged due to a heightened risk of gastrointestinal ulceration and hemorrhage. Physician consultation is recommended prior to combining these drugs.
Nimkis 100mg Delayed-Release Tablets are a non-steroidal anti-inflammatory medication used for pain relief. This formulation is aspirin-free.
Using Nimkis 100mg DT tablets as directed by a physician is considered safe.
Use of Nimkis 100mg Delayed-Release tablets for headache relief should only occur under physician supervision.
Taking the recommended dose of Nimkis 100mg Tablet DT will not cause drowsiness. Nevertheless, exceeding the prescribed dosage of Nimkis 100mg Tablet DT may induce drowsiness.
Nimkis 100mg Tablet DT is free of sulfur.
Nimkis 100mg Delayed-Release Tablets are indicated for the management of acute pain, the discomfort associated with osteoarthritis, and primary dysmenorrhea in patients aged 12 and older.
Nimkis 100mg Delayed-Release tablets may be used concurrently with ibuprofen. While no documented interactions exist, combined use isn't recommended due to a heightened risk of stomach ulcers and bleeding. Physician consultation is advised prior to concomitant administration.
Concurrent use of Nimkis 100mg Delayed-Release tablets and aspirin is permissible. Clinical trials have not revealed any drug interactions. Nevertheless, the possibility of interactions remains. Physician consultation is advised prior to combined administration.
The sale of Nimkis 100mg Tablet DT is permitted in India. Nevertheless, India's Ministry of Health and Family Welfare prohibits its use by children below the age of twelve.
The presence of Nimkis 100mg Tablet DT in breast milk is undetermined. Therefore, medications including Nimkis 100mg Tablet DT should be avoided while breastfeeding.
The use of Nimkis 100mg Tablet DT during pregnancy, particularly in the final trimester, is not recommended due to safety concerns. Reports indicate a link between maternal Nimkis 100mg Tablet DT use in late pregnancy and kidney problems in newborns. Pregnant individuals should always seek medical advice before using any medication.
Patients with asthma can generally use Nimkis 100mg Tablet DT safely, provided they follow their physician's instructions. Nevertheless, individuals with asthma should always disclose their condition and any other medications they are taking to their doctor before starting Nimkis 100mg Tablet DT.
Nimkis 100mg Tablet DT
21
MRP 25
16% off